Session III of the Business Group’s multi-session Opioid Summit will feature work conducted by Shatterproof and Cigna on a Treatment Task Force, as well as highlight GE’s workplace program.
The misuse and abuse of prescription opioids is a growing concern for large employers and impacts employee productivity, workplace costs, absenteeism and disability costs, workers compensation claims, and overall medical expenses. At the same time, behavioral health is an increasing area of focus among employers and companies are making attempts to improve access and reduce the stigma associated with behavioral health treatment, including addiction. To help employers navigate this issue, the National Business Group on Health will convene experts to bring understanding to key challenges associated with the misuse and abuse of prescription opioids. Please join us for the 2018 Opioid Summit, Session III: “Opioids on the Job: A Multi-part Series on Addressing a Crisis in the American Workforce” to learn more.
Gary Mendell, Founder & CEO, Shatterproof
Adam Malinoski, Manager, Health Services, Clinical Programs, GE
Doug Nemecek, M.D., M.B.A, Chief Medical Officer for Behavioral Health, Cigna